Moreover hypermethylation of the DACT2 promoter was reported in advanced NAFLD individuals compared with mild NAFLD patients [46], which is consistent with its low expression in HCCs. This evidence concerns the gene DACT2 and metabolic dysfunction-associated steatotic liver disease.